Paloma Partners Management CO Collegium Pharmaceutical, Inc Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$10.62 - $16.59 $125,539 - $196,110
-11,821 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$13.58 - $18.72 $160,529 - $221,289
11,821 New
11,821 $179,000
Q2 2018

Aug 14, 2018
SELL
$21.79 - $28.29 $465,891 - $604,868
-21,381 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$18.15 - $29.21 $388,065 - $624,539
21,381 New
21,381 $546,000

Others Institutions Holding COLL

# of Institutions
255
Shares Held
38.6M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.01B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email